<TITLE>910/153/18</TITLE>
<!-- BEGIN METADATA -->
<!-- Íàéìåíóâàííÿ ôàéëà ç ð³øåííÿì -->
<META NAME="FILENAME" CONTENT="5011_7785439.html">
<!-- 1,2 ID ð³øåííÿ TAGNAME(DOCID, DOCORGID) - íóæíî äëÿ ïîëó÷åíèÿ ïîäòâåðæäåíèÿ ðååñòðàöèè -->
<META NAME="DOCID" CONTENT="7785439">
<META NAME="DOCORGID" CONTENT="1">
<!-- [3] Íàéìåíóâàííÿ ñóäó, ÿêèé óõâàëèâ (ïîñòàíîâèâ) ñóäîâå ð³øåííÿ TAGNAME(COURTNAME) -->
<META NAME="COURTNAME" CONTENT="Ãîñïîäàðñüêèé ñóä ì³ñòà Êèºâà">
<!-- [4] Êîä ñóäó, ÿêèé óõâàëèâ (ïîñòàíîâèâ) ñóäîâå ð³øåííÿ TAGNAME(CAUSECOURT) -->
<META NAME="CAUSECOURT" CONTENT="5011">
<!-- [4.1] Êîä ñóäó, ÿêèé óõâàëèâ (ïîñòàíîâèâ) ñóäîâå ð³øåííÿ TAGNAME(CAUSECOURT2013) -->
<META NAME="CAUSECOURT2013" CONTENT="910">
<!-- [5] Ñïðàâà íîìåð TAGNAME(CAUSENUM) -->
<META NAME="CAUSENUM" CONTENT="910/153/18">
<!-- [6] Äàòà ñïðàâè TAGNAME(CAUSEDATE) -->
<META NAME="CAUSEDATE" CONTENT="03.01.2018">
<!-- [7] Äàòà óõâàëåííÿ ð³øåííÿ TAGNAME(DOCDATE) -->
<META NAME="DOCDATE" CONTENT="09.01.2018">
<!-- [9] Ôîðìà ð³øåííÿ (ID) TAGNAME(DOCTYPE) -->
<!-- ð³øåííÿ = 2 -->
<!-- ïîñòàíîâà = 3 -->
<!-- óõâàëà ñóäó = 4 -->
<!-- ñóäîâèé íàêàç = 5 -->
<!-- îêðåìà óõâàëà = 6 -->
<META NAME="DOCTYPE" CONTENT="4">
<!-- [10] Ôîðìà ñóäî÷èíñòâà (ID) TAGNAME(CAUSETYPE) -->
<!-- àäì³í³ñòðàòèâíà = 1 -->
<!-- êðèì³íàëüíà = 2 -->
<!-- ãîñïîäàðñüêà = 3 -->
<!-- öèâ³ëüíà = 4 -->
<!-- àäì³í³ñòðàòèâíå ïðàâîïîðóøåííÿ = 5 -->
<META NAME="CAUSETYPE" CONTENT="3">
<!-- [11] Êîä êàòåãîð³¿ ñïðàâè TAGNAME(CAUSECATEGORY) -->
<!-- [12] Ñïðàâà ðîçãëÿäàºòüñÿ ïî ³íñòàíö³¿ (ID) TAGNAME(CAUSELOCATION) -->
<!-- àïåëÿö³éí³é = A -->
<!-- êàñàö³éí³é = C -->
<META NAME="CAUSELOCATION" CONTENT="P">
<!-- [13] Ïîïåðåäí³é íîìåð ïîòî÷íî¿ ñóäîâî¿ ñïðàâè TAGNAME(REREGCAUSENUM) -->
<!-- [14] Ïîïåðåäíÿ äàòà ïîòî÷íî¿ ñóäîâî¿ ñïðàâè TAGNAME(REREGCAUSEDATE) -->
<!-- [15] Íîìåð ñóäîâî¿ ñïðàâè, ð³øåííÿ â ÿê³é ïåðåãëÿäàºòüñÿ TAGNAME(PREVCAUSENUM) -->
<!-- [16] Äàòà ñóäîâî¿ ñïðàâè, ð³øåííÿ â ÿê³é ïåðåãëÿäàºòüñÿ TAGNAME(PREVCAUSEDATE) -->
<!-- [17] Äàòà óõâàëåííÿ (ïîñòàíîâëåííÿ) ñóäîâîãî ð³øåííÿ, ùî ïåðåãëÿäàºòüñÿ TAGNAME(PREVRESCAUSEDATE) -->
<!-- [18] Ñóä, ùî óõâàëèâ (ïîñòàíîâèâ) ñóäîâå ð³øåííÿ, ÿêå ïåðåãëÿäàºòüñÿ TAGNAME(PREVCOURTNAME) -->
<!-- [19] Êîä ñóäó, ùî óõâàëèâ (ïîñòàíîâèâ) ñóäîâå ð³øåííÿ, ÿêå ïåðåãëÿäàºòüñÿ TAGNAME(PREVCAUSECOURT) -->
<!-- [19.1] Êîä ñóäó, ùî óõâàëèâ (ïîñòàíîâèâ) ñóäîâå ð³øåííÿ, ÿêå ïåðåãëÿäàºòüñÿ TAGNAME(PREVCAUSECOURT2013) -->
<!-- [20] Êîä êàòåãîð³¿ ïîïåðåäíüî¿ ñïðàâè TAGNAME(PREVCAUSECATEGORY) -->
<!-- [21] Ñåêðåòàð ñóäîâîãî çàñ³äàííÿ TAGNAME(SECRETARY) -->
<!-- [22] Çàáîðîíà îïðèëþäíåííÿ TAGNAME(HEARINGCLOSED) -->
<!-- íå çàáîðîíåíî = V -->
<!-- çàáîðîíåíî = Z -->
<!-- çàáîðîíåíî òèì÷àñîâî = T -->
<META NAME="HEARINGCLOSED" CONTENT="V">
<!-- [23] Ê³ëüê-òü àðêóø³â äîêóìåíòà (ÍÅ Ï²ÄÒÐÈÌÓªÒÜÑß) -->
<!-- Ñóää³ â ð³øåíí³: -->
<!-- [24] Ïîðÿäêîâèé íîìåð TAGNAME(JUDGEPOSITION) -->
<META NAME="JUDGEPOSITION1" CONTENT="1">
<!-- [25] ÏÐ²ÇÂÈÙÅ, ²Í²Ö²ÀËÈ TAGNAME(JUDGENAME) -->
<META NAME="JUDGENAME1" CONTENT="Ë³òâ³íîâà Ì.ª.">
<!-- [26] ÊÎÄ ÑÓÄÄ² TAGNAME(JUDGECODE) -->
<!-- Ñòîðîíè ð³øåííÿ: -->
<!-- [27] Ïîðÿäêîâèé íîìåð TAGNAME(MEMBPOSITION) -->
<META NAME="MEMBPOSITION1" CONTENT="1">
<!-- [28] Òèï ñòîðîíè (ID): TAGNAME(MEMBTYPE) -->
<!-- ïîçèâà÷ = P -->
<!-- â³äïîâ³äà÷ = V -->
<META NAME="MEMBTYPE1" CONTENT="P">
<!-- [29] Òèï ïîçèâà÷à (ID): TAGNAME(MEMBPOZYVACHTYPE) -->
<!-- ïîçèâà÷ = P -->
<!-- çàÿâíèê = Z -->
<!-- ñòÿãóâà÷ = S -->
<!-- êðåäèòîð = K -->
<!-- îáâèíóâà÷ = B -->
<!-- öèâ³ëüíèé ïîçèâà÷ = C -->
<!-- çà³íòåðåñîâàíà îñîáà = A -->
<!-- ³íøà îñîáà = I -->
<META NAME="MEMBPOZYVACHTYPE1" CONTENT="P">
<!-- [30] Òèï â³äïîâ³äà÷à (ID): TAGNAME(MEMBVIDPOVIDACHTYPE) -->
<!-- â³äïîâ³äà÷ = V -->
<!-- öèâ³ëüíèé â³äïîâ³äà÷ = C -->
<!-- àäì³í.ïðàâîïîðóøíèê = P -->
<!-- áîðæíèê = B -->
<!-- ï³äñóäíèé = D -->
<!-- ³íøà îñîáà = I -->
<META NAME="MEMBVIDPOVIDACHTYPE1" CONTENT="">
<!-- [31] Òèï îñîáè (ID): TAGNAME(MEMBOSOBATYPE) -->
<!-- þðèäè÷íà = U -->
<!-- ô³çè÷íà = F -->
<META NAME="MEMBOSOBATYPE1" CONTENT="U">
<!-- [32] Ïîâíà íàçâà (äëÿ þðèäè÷íèõ) àáî Ïð³çâèùå òà ³í³ö³àëè (äëÿ ô³çè÷íèõ) TAGNAME(MEMBNAME) -->
<META NAME="MEMBNAME1" CONTENT="Ïðèâàòíå àêö³îíåðíå òîâàðèñòâî &quot;Êè¿âñüêèé â³òàì³ííèé çàâîä&quot;">
<!-- [33] Öèôðîâå àáî ë³òåðíå ïîçíà÷åííÿ TAGNAME(MEMBSHORT) -->
<META NAME="MEMBSHORT1" CONTENT="Ïîçèâà÷ 1">
<!-- [34] Êîä ªÄÐÏÎÓ (äëÿ þðèäè÷íèõ) TAGNAME(MEMBOKPO) -->
<META NAME="MEMBOKPO1" CONTENT="35251822">
<!-- [35] Äàòà íàðîäæåííÿ (äëÿ ô³çè÷íèõ) - ÍÅ Ï²ÄÒÐÈÌÓªÒÜÑß -->
<!-- [36] Àäðåñà (äëÿ þðèäè÷íèõ) àáî Ì³ñöåçíàõîäæåííÿ (äëÿ ô³çè÷íèõ) TAGNAME(MEMBPOSTADDRESS) -->
<!-- [37] ×àñòêà äåðæâëàñíîñò³ TAGNAME(CHASTDERGVL) ÇÍÀ×ÅÍÈÅ(TRUE|FALSE) -->
<META NAME="CHASTDERGVL1" CONTENT="FALSE">
<!-- [27] Ïîðÿäêîâèé íîìåð TAGNAME(MEMBPOSITION) -->
<META NAME="MEMBPOSITION2" CONTENT="2">
<!-- [28] Òèï ñòîðîíè (ID): TAGNAME(MEMBTYPE) -->
<!-- ïîçèâà÷ = P -->
<!-- â³äïîâ³äà÷ = V -->
<META NAME="MEMBTYPE2" CONTENT="V">
<!-- [29] Òèï ïîçèâà÷à (ID): TAGNAME(MEMBPOZYVACHTYPE) -->
<!-- ïîçèâà÷ = P -->
<!-- çàÿâíèê = Z -->
<!-- ñòÿãóâà÷ = S -->
<!-- êðåäèòîð = K -->
<!-- îáâèíóâà÷ = B -->
<!-- öèâ³ëüíèé ïîçèâà÷ = C -->
<!-- çà³íòåðåñîâàíà îñîáà = A -->
<!-- ³íøà îñîáà = I -->
<META NAME="MEMBPOZYVACHTYPE2" CONTENT="">
<!-- [30] Òèï â³äïîâ³äà÷à (ID): TAGNAME(MEMBVIDPOVIDACHTYPE) -->
<!-- â³äïîâ³äà÷ = V -->
<!-- öèâ³ëüíèé â³äïîâ³äà÷ = C -->
<!-- àäì³í.ïðàâîïîðóøíèê = P -->
<!-- áîðæíèê = B -->
<!-- ï³äñóäíèé = D -->
<!-- ³íøà îñîáà = I -->
<META NAME="MEMBVIDPOVIDACHTYPE2" CONTENT="V">
<!-- [31] Òèï îñîáè (ID): TAGNAME(MEMBOSOBATYPE) -->
<!-- þðèäè÷íà = U -->
<!-- ô³çè÷íà = F -->
<META NAME="MEMBOSOBATYPE2" CONTENT="U">
<!-- [32] Ïîâíà íàçâà (äëÿ þðèäè÷íèõ) àáî Ïð³çâèùå òà ³í³ö³àëè (äëÿ ô³çè÷íèõ) TAGNAME(MEMBNAME) -->
<META NAME="MEMBNAME2" CONTENT="Glaxosmithkline Trading Services Limited">
<!-- [33] Öèôðîâå àáî ë³òåðíå ïîçíà÷åííÿ TAGNAME(MEMBSHORT) -->
<META NAME="MEMBSHORT2" CONTENT="Â³äïîâ³äà÷ 1">
<!-- [34] Êîä ªÄÐÏÎÓ (äëÿ þðèäè÷íèõ) TAGNAME(MEMBOKPO) -->
<META NAME="MEMBOKPO2" CONTENT="">
<!-- [35] Äàòà íàðîäæåííÿ (äëÿ ô³çè÷íèõ) - ÍÅ Ï²ÄÒÐÈÌÓªÒÜÑß -->
<!-- [36] Àäðåñà (äëÿ þðèäè÷íèõ) àáî Ì³ñöåçíàõîäæåííÿ (äëÿ ô³çè÷íèõ) TAGNAME(MEMBPOSTADDRESS) -->
<META NAME="MEMBPOSTADDRESS2" CONTENT="Êàðåá³í³, Êàðð³ãàë³í, Êàóíò³ Êîðê ²ðëàíä³ÿ">
<!-- [37] ×àñòêà äåðæâëàñíîñò³ TAGNAME(CHASTDERGVL) ÇÍÀ×ÅÍÈÅ(TRUE|FALSE) -->
<META NAME="CHASTDERGVL2" CONTENT="FALSE">
<!-- [27] Ïîðÿäêîâèé íîìåð TAGNAME(MEMBPOSITION) -->
<META NAME="MEMBPOSITION3" CONTENT="3">
<!-- [28] Òèï ñòîðîíè (ID): TAGNAME(MEMBTYPE) -->
<!-- ïîçèâà÷ = P -->
<!-- â³äïîâ³äà÷ = V -->
<META NAME="MEMBTYPE3" CONTENT="V">
<!-- [29] Òèï ïîçèâà÷à (ID): TAGNAME(MEMBPOZYVACHTYPE) -->
<!-- ïîçèâà÷ = P -->
<!-- çàÿâíèê = Z -->
<!-- ñòÿãóâà÷ = S -->
<!-- êðåäèòîð = K -->
<!-- îáâèíóâà÷ = B -->
<!-- öèâ³ëüíèé ïîçèâà÷ = C -->
<!-- çà³íòåðåñîâàíà îñîáà = A -->
<!-- ³íøà îñîáà = I -->
<META NAME="MEMBPOZYVACHTYPE3" CONTENT="">
<!-- [30] Òèï â³äïîâ³äà÷à (ID): TAGNAME(MEMBVIDPOVIDACHTYPE) -->
<!-- â³äïîâ³äà÷ = V -->
<!-- öèâ³ëüíèé â³äïîâ³äà÷ = C -->
<!-- àäì³í.ïðàâîïîðóøíèê = P -->
<!-- áîðæíèê = B -->
<!-- ï³äñóäíèé = D -->
<!-- ³íøà îñîáà = I -->
<META NAME="MEMBVIDPOVIDACHTYPE3" CONTENT="V">
<!-- [31] Òèï îñîáè (ID): TAGNAME(MEMBOSOBATYPE) -->
<!-- þðèäè÷íà = U -->
<!-- ô³çè÷íà = F -->
<META NAME="MEMBOSOBATYPE3" CONTENT="U">
<!-- [32] Ïîâíà íàçâà (äëÿ þðèäè÷íèõ) àáî Ïð³çâèùå òà ³í³ö³àëè (äëÿ ô³çè÷íèõ) TAGNAME(MEMBNAME) -->
<META NAME="MEMBNAME3" CONTENT="Ì³í³ñòåðñòâî åêîíîì³÷íîãî ðîçâèòêó ³ òîðã³âë³ Óêðà¿íè">
<!-- [33] Öèôðîâå àáî ë³òåðíå ïîçíà÷åííÿ TAGNAME(MEMBSHORT) -->
<META NAME="MEMBSHORT3" CONTENT="Â³äïîâ³äà÷ 2">
<!-- [34] Êîä ªÄÐÏÎÓ (äëÿ þðèäè÷íèõ) TAGNAME(MEMBOKPO) -->
<META NAME="MEMBOKPO3" CONTENT="37508596">
<!-- [35] Äàòà íàðîäæåííÿ (äëÿ ô³çè÷íèõ) - ÍÅ Ï²ÄÒÐÈÌÓªÒÜÑß -->
<!-- [36] Àäðåñà (äëÿ þðèäè÷íèõ) àáî Ì³ñöåçíàõîäæåííÿ (äëÿ ô³çè÷íèõ) TAGNAME(MEMBPOSTADDRESS) -->
<!-- [37] ×àñòêà äåðæâëàñíîñò³ TAGNAME(CHASTDERGVL) ÇÍÀ×ÅÍÈÅ(TRUE|FALSE) -->
<META NAME="CHASTDERGVL3" CONTENT="FALSE">
<!-- [38] Âåðñ³ÿ êë³ºíòà TAGNAME(APPVER) -->
<META NAME="APPVER" CONTENT="1.32.0.175">
<!-- [39] Êîä ïðîâàéäåðà ÅÖÏ TAGNAME(CRYPTPROVIDER) -->
<META NAME="CRYPTPROVIDER" CONTENT="DS13">
<!-- END METADATA -->
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=windows-1251">
<META NAME="Author" CONTENT="">
<META NAME="Description" CONTENT="Document">
<META NAME="Document-state" CONTENT="static">
<META NAME="Updated" CONTENT="09.01.2018 13:35:39">
<META NAME="Robots" CONTENT="All">
<META NAME="Keywords" CONTENT="">
<STYLE TYPE="text/css">
margin-right: 10 mm;
margin-bottom: 10 mm;
mso-paper-source: 0;
@charset "Windows-1251";
font-family: Times New Roman;
font-family: Facefont SSH;
font-family: Facefont SSH;
vertical-align: sub;
font-family: Calibri;
font-family: Times New Roman;
margin-bottom: 0 mm;
white-space: normal;
word-spacing: normal;
text-align: justify;
text-align: justify;
text-align: justify;
border-color: black;
margin-bottom: 0 px;
margin-right: 10 px;
background-color: white;
table-layout: fixed;
margin-bottom: 10 px;
border-color: black;
border-style: solid;
border-top-width: 1 px;
border-bottom-width: 1 px;
border-left-width: 1 px;
border-right-width: 1 px;
padding-bottom: 1 px;
padding-right: 5 px;);
border-left-width: 0 mm;
border-right-width: 0 mm;
border-top-width: 0 mm;
border-bottom-width: 1.0583 mm;
border-left-style: none;
border-right-style: none;
border-top-style: none;
border-bottom-style: ;
border-left-width: 0.088194 mm;
border-right-width: 0.088194 mm;
border-top-width: 0.088194 mm;
border-bottom-width: 0.088194 mm;
border-left-color: White;
border-right-color: White;
border-top-color: White;
border-bottom-color: White;
padding-right: 1 mm;
<TABLE cellspacing=0 px class="tslast">
<TR><TD width="100 %" class="tds1"><P class="ps10"><FONT class="fs165"> &nbsp;</FONT><FONT class="fs163"><IMG src="herb.gif" height=70 width=52></FONT></P><BR>
<P class="ps5"><FONT class="fs105">ÓÕÂÀËÀ</FONT></P>
<P class="ps5"><FONT class="fs104">ÏÐÎ Â²ÄÊÐÈÒÒß ÏÐÎÂÀÄÆÅÍÍß Ó ÑÏÐÀÂ²</FONT></P>
<TABLE cellspacing=0 px class="tslast">
<TR><TD width="50 %" class="tds6"><P><FONT class="fs103"> 09.01.2018</FONT></P></TD><TD width="50 %" class="tds6"><P class="ps9"><FONT class="fs102">Ñïðàâà ¹ &nbsp;910/153/18</FONT></P></TD></TR>
<P><FONT class="fs159"> </FONT></P>
<P class="ps2"><FONT class="fs158">Ñóääÿ ãîñïîäàðñüêîãî ñóäó ì³ñòà Êèºâà Ë³òâ³íîâà Ì.ª., ðîçãëÿíóâøè </FONT></P>
<P class="ps1"><FONT class="fs101">ïîçîâíó çàÿâó</FONT><FONT class="fs157">           Ïðèâàòíîãî àêö³îíåðíîãî òîâàðèñòâà «Êè¿âñüêèé â³òàì³ííèé çàâîä», </FONT></P>
<P class="ps1"><FONT class="fs156">                              ì³ñòî Êè¿â                               &nbsp;</FONT></P>
<P class="ps1"><FONT class="fs100">äî          </FONT><FONT class="fs155">                     1. Glaxosmithkline Trading &nbsp;Services Limited, ²ðëàíä³ÿ</FONT></P>
<P class="ps1"><FONT class="fs154">                               2. Ì³í³ñòåðñòâà åêîíîì³÷íîãî ðîçâèòêó ³ òîðã³âë³ Óêðà¿íè, ì³ñòî Êè¿â &nbsp;&nbsp;</FONT></P>
<P class="ps1"><FONT class="fs99">ïðî</FONT><FONT class="fs153">                              äîñòðîêîâå ïðèïèíåííÿ Ñâ³äîöòâ òà çîáîâÿçàííÿ â÷èíèòè ä³¿,</FONT></P>
<P class="ps4"><FONT class="fs98">ÂÑÒÀÍÎÂÈÂ:</FONT></P>
<P class="ps1"><FONT class="fs152">          Ïðèâàòíå àêö³îíåðíå òîâàðèñòâî «Êè¿âñüêèé â³òàì³íí³é çàâîä» (äàë³  ïîçèâà÷) çâåðíóëîñü äî ãîñïîäàðñüêîãî ñóäó ì³ñòà Êèºâà ç ïîçîâîì äî Glaxosmithkline Trading &nbsp;Services Limited (äàë³  â³äïîâ³äà÷-1) òà Ì³í³ñòåðñòâà åêîíîì³÷íîãî ðîçâèòêó ³ òîðã³âë³ Óêðà¿íè (äàë³  â³äïîâ³äà÷-2) ïðî:</FONT></P>
<P class="ps3"><FONT class="fs151">-          äîñòðîêîâå ïðèïèíåííÿ ïîâí³ñòþ íà òåðèòîð³¿ Óêðà¿íè ä³¿ â Óêðà¿í³ Ñâ³äîöòâà Óêðà¿íè ¹ 141162 â³ä 11.07.2011 íà çíàê äëÿ òîâàð³â ³ ïîñëóã ÐÈÄÎÊÀÐ ó â³äíîøåíí³ âñ³õ òîâàð³â òà ïîñëóã 05 êëàñó Ì³æíàðîäíî¿ êëàñèô³êàö³¿ òîâàð³â ³ ïîñëóã, äëÿ ÿêèõ éîãî çàðåºñòðîâàíî íà ³ìÿ Glaxosmithkline Trading &nbsp;Services Limited;</FONT></P>
<P class="ps3"><FONT class="fs150">-          çîáîâÿçàííÿ Ì³í³ñòåðñòâà åêîíîì³÷íîãî ðîçâèòêó ³ òîðã³âë³ Óêðà¿íè âíåñòè äî Äåðæàâíîãî ðåºñòðó ñâ³äîöòâ Óêðà¿íè íà çíàêè äëÿ òîâàð³â ³ ïîñëóã â³äîìîñò³ ïðî âèçíàííÿ íåä³éñíèì ïîâí³ñòþ Ñâ³äîöòâà Óêðà¿íè ¹ 141162 â³ä 11.07.2011 íà çíàê äëÿ òîâàð³â ³ ïîñëóã ÐÈÄÎÊÀÐ ó â³äíîøåíí³ âñ³õ òîâàð³â òà ïîñëóã 05 êëàñó Ì³æíàðîäíî¿ êëàñèô³êàö³¿ òîâàð³â ³ ïîñëóã, äëÿ ÿêèõ éîãî çàðåºñòðîâàíî íà ³ìÿ Glaxosmithkline Trading &nbsp;Services Limited òà çä³éñíèòè ïóáë³êàö³þ ïðî öå â ñâîºìó îô³ö³éíîìó áþëåòåí³;</FONT></P>
<P class="ps3"><FONT class="fs149">-          äîñòðîêîâå ïðèïèíåííÿ ïîâí³ñòþ íà òåðèòîð³¿ Óêðà¿íè ä³¿ â Óêðà¿í³ Ñâ³äîöòâà Óêðà¿íè ¹ 139653 â³ä 10.06.2011 íà çíàê äëÿ òîâàð³â ³ ïîñëóã RIDOKARE &nbsp;ó â³äíîøåíí³ âñ³õ òîâàð³â òà ïîñëóã 05 êëàñó Ì³æíàðîäíî¿ êëàñèô³êàö³¿ òîâàð³â ³ ïîñëóã, äëÿ ÿêèõ éîãî çàðåºñòðîâàíî íà ³ìÿ Glaxosmithkline Trading &nbsp;Services Limited;</FONT></P>
<P class="ps3"><FONT class="fs148">-          çîáîâÿçàííÿ Ì³í³ñòåðñòâà åêîíîì³÷íîãî ðîçâèòêó ³ òîðã³âë³ Óêðà¿íè âíåñòè äî Äåðæàâíîãî ðåºñòðó ñâ³äîöòâ Óêðà¿íè íà çíàêè äëÿ òîâàð³â ³ ïîñëóã â³äîìîñò³ ïðî âèçíàííÿ íåä³éñíèì ïîâí³ñòþ Ñâ³äîöòâà Óêðà¿íè ¹ 139653 â³ä 10.06.2011 íà çíàê äëÿ òîâàð³â ³ ïîñëóã RIDOKARE ó â³äíîøåíí³ âñ³õ òîâàð³â òà ïîñëóã 05 êëàñó Ì³æíàðîäíî¿ êëàñèô³êàö³¿ òîâàð³â ³ ïîñëóã, äëÿ ÿêèõ éîãî çàðåºñòðîâàíî íà ³ìÿ Glaxosmithkline Trading &nbsp;Services Limited òà çä³éñíèòè ïóáë³êàö³þ ïðî öå â ñâîºìó îô³ö³éíîìó áþëåòåí³;</FONT></P>
<P class="ps1"><FONT class="fs147">          Îá´ðóíòîâóþ÷è çàÿâëåí³ ïîçîâí³ âèìîãè ïîçèâà÷ âêàçóº íà òå, ùî â³í çâåðíóâñÿ äî â³äïîâ³äà÷à-2 ³ç çàÿâêîþ ïðî ðåºñòðàö³þ ïîçíà÷åííÿ ÑÈÄÎÊÀÐÄ â ÿêîñò³ çíàêà äëÿ òîâàð³â ³ ïîñëóã 05 êëàñó Ì³æíàðîäíî¿ êëàñèô³êàö³¿ òîâàð³â ³ ïîñëóã äëÿ ðåºñòðàö³¿ çíàê³â, ïðîòå â ïîäàëüøîìó, ïîçèâà÷ âèÿâèâ ÷èíí³ â Óêðà¿í³ ðåºñòðàö³¿ çíàê³â äëÿ òîâàð³â ³ ïîñëóã íà çíàêè äëÿ òîâàð³â ÐÈÄÎÊÀÐ òà RIDOKARE, ÿê³ çàðåºñòðîâàí³ çà â³äïîâ³äà÷åì-1. Òàêèì ÷èíîì, ïîçèâà÷ ââàæàº, ùî çíàêè äëÿ òîâàð³â ³ ïîñëóã çà îñïîðþâàíèìè Ñâ³äîöòâàìè ìîæóòü ñòâîðþâàòè ïåðåøêîäè ïîçèâà÷ó ó ðåàë³çàö³¿ ïðàâ ³íòåëåêòóàëüíî¿ âëàñíîñò³ íà ïîçíà÷åííÿ ÑÈÄÎÊÀÐÄ. </FONT></P>
<P class="ps1"><FONT class="fs146">          Ðîçãëÿíóâøè ìàòåð³àëè ïîçîâíî¿ çàÿâè, ñóäîì âñòàíîâëåíî, ùî âîíà â³äïîâ³äàº âèìîãàì, âèêëàäåíèì ó ñòàòòÿõ 162, 164, 172 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè, à ïîäàí³ ìàòåð³àëè º äîñòàòí³ìè äëÿ ïðèéíÿòòÿ ïîçîâíî¿ çàÿâè äî ðîçãëÿäó òà â³äêðèòòÿ ïðîâàäæåííÿ ó ñïðàâ³. </FONT></P>
<P class="ps1"><FONT class="fs145">           ×àñòèíîþ 1 ñòàòò³ 12 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè ïåðåäáà÷åíî, ùî ãîñïîäàðñüêå ñóäî÷èíñòâî çä³éñíþºòüñÿ çà ïðàâèëàìè, ïåðåäáà÷åíèìè öèì Êîäåêñîì, ó ïîðÿäêó, çîêðåìà, ïîçîâíîãî ïðîâàäæåííÿ (çàãàëüíîãî àáî ñïðîùåíîãî).</FONT></P>
<P class="ps2"><FONT class="fs144">Ñïðîùåíå ïîçîâíå ïðîâàäæåííÿ ïðèçíà÷åíå äëÿ ðîçãëÿäó ìàëîçíà÷íèõ ñïðàâ, ñïðàâ íåçíà÷íî¿ ñêëàäíîñò³ òà ³íøèõ ñïðàâ, äëÿ ÿêèõ ïð³îðèòåòíèì º øâèäêå âèð³øåííÿ ñïðàâè. Çàãàëüíå ïîçîâíå ïðîâàäæåííÿ ïðèçíà÷åíå äëÿ ðîçãëÿäó ñïðàâ, ÿê³ ÷åðåç ñêëàäí³ñòü àáî ³íø³ îáñòàâèíè íåäîö³ëüíî ðîçãëÿäàòè ó ñïðîùåíîìó ïîçîâíîìó ïðîâàäæåíí³ (÷àñòèíà 3 ñòàòò³ 12 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè). </FONT></P>
<P class="ps2"><FONT class="fs143">Â³äïîâ³äíî äî ÷àñòèíè 3 ñòàòò³ 247 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè ïðè âèð³øåíí³ ïèòàííÿ ïðî ðîçãëÿä ñïðàâè â ïîðÿäêó ñïðîùåíîãî àáî çàãàëüíîãî ïîçîâíîãî ïðîâàäæåííÿ ñóä âðàõîâóº: 1) ö³íó ïîçîâó; 2) çíà÷åííÿ ñïðàâè äëÿ ñòîð³í; 3) îáðàíèé ïîçèâà÷åì ñïîñ³á çàõèñòó; 4) êàòåãîð³þ òà ñêëàäí³ñòü ñïðàâè; 5) îáñÿã òà õàðàêòåð äîêàç³â ó ñïðàâ³, â òîìó ÷èñë³ ÷è ïîòð³áíî ó ñïðàâ³ ïðèçíà÷èòè åêñïåðòèçó, âèêëèêàòè ñâ³äê³â òîùî; 6) ê³ëüê³ñòü ñòîð³í òà ³íøèõ ó÷àñíèê³â ñïðàâè; 7) ÷è ñòàíîâèòü ðîçãëÿä ñïðàâè çíà÷íèé ñóñï³ëüíèé ³íòåðåñ; 8) äóìêó ñòîð³í ùîäî íåîáõ³äíîñò³ ðîçãëÿäó ñïðàâè çà ïðàâèëàìè ñïðîùåíîãî ïîçîâíîãî ïðîâàäæåííÿ.</FONT></P>
<P class="ps2"><FONT class="fs142">Ó ïîðÿäêó ñïðîùåíîãî ïîçîâíîãî ïðîâàäæåííÿ íå ìîæóòü áóòè ðîçãëÿíóò³ ñïðàâè:</FONT></P>
<P class="ps2"><FONT class="fs141">1) ïðî áàíêðóòñòâî;</FONT></P>
<P class="ps2"><FONT class="fs140">2) çà çàÿâàìè ïðî çàòâåðäæåííÿ ïëàí³â ñàíàö³¿ áîðæíèêà äî â³äêðèòòÿ ïðîâàäæåííÿ ó ñïðàâ³ ïðî áàíêðóòñòâî;</FONT></P>
<P class="ps2"><FONT class="fs139">3) ó ñïîðàõ, ÿê³ âèíèêàþòü ç êîðïîðàòèâíèõ â³äíîñèí, òà ñïîðàõ ç ïðàâî÷èí³â ùîäî êîðïîðàòèâíèõ ïðàâ (àêö³é);</FONT></P>
<P class="ps2"><FONT class="fs138">4) ó ñïîðàõ ùîäî çàõèñòó ïðàâ ³íòåëåêòóàëüíî¿ âëàñíîñò³, êð³ì ñïðàâ ïðî ñòÿãíåííÿ ãðîøîâî¿ ñóìè, ðîçì³ð ÿêî¿ íå ïåðåâèùóº ñòà ðîçì³ð³â ïðîæèòêîâîãî ì³í³ìóìó äëÿ ïðàöåçäàòíèõ îñ³á;</FONT></P>
<P class="ps2"><FONT class="fs137">5) ó ñïîðàõ, ùî âèíèêàþòü ç â³äíîñèí, ïîâÿçàíèõ ³ç çàõèñòîì åêîíîì³÷íî¿ êîíêóðåíö³¿, îáìåæåííÿì ìîíîïîë³çìó â ãîñïîäàðñüê³é ä³ÿëüíîñò³, çàõèñòîì â³ä íåäîáðîñîâ³ñíî¿ êîíêóðåíö³¿;</FONT></P>
<P class="ps2"><FONT class="fs136">6) ó ñïîðàõ ì³æ þðèäè÷íîþ îñîáîþ òà ¿¿ ïîñàäîâîþ îñîáîþ (ó òîìó ÷èñë³ ïîñàäîâîþ îñîáîþ, ïîâíîâàæåííÿ ÿêî¿ ïðèïèíåí³) ïðî â³äøêîäóâàííÿ çáèòê³â, çàïîä³ÿíèõ òàêîþ ïîñàäîâîþ îñîáîþ þðèäè÷í³é îñîá³ ¿¿ ä³ÿìè (áåçä³ÿëüí³ñòþ);</FONT></P>
<P class="ps2"><FONT class="fs135">7) ó ñïîðàõ ùîäî ïðèâàòèçàö³¿ äåðæàâíîãî ÷è êîìóíàëüíîãî ìàéíà;</FONT></P>
<P class="ps2"><FONT class="fs134">8) â ÿêèõ ö³íà ïîçîâó ïåðåâèùóº ïÿòñîò ðîçì³ð³â ïðîæèòêîâîãî ì³í³ìóìó äëÿ ïðàöåçäàòíèõ îñ³á;</FONT></P>
<P class="ps2"><FONT class="fs133">9) ³íø³ âèìîãè, îáºäíàí³ ç âèìîãàìè ó ñïîðàõ, âêàçàíèõ ó ïóíêòàõ 3-8 ö³º¿ ÷àñòèíè.</FONT></P>
<P class="ps2"><FONT class="fs132">Çà òàêèõ îáñòàâèí, ñóä ä³éøîâ âèñíîâêó, ùî ñïðàâà ¹ 910/153/18 ï³äëÿãàº ðîçãëÿäó â ïîðÿäêó çàãàëüíîãî ïîçîâíîãî ïðîâàäæåííÿ. </FONT></P>
<P class="ps2"><FONT class="fs131">Ïîëîæåííÿìè ñòàòò³ 181 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè ïåðåäáà÷åíî, ùî äëÿ âèêîíàííÿ çàâäàííÿ ï³äãîòîâ÷îãî ïðîâàäæåííÿ â êîæí³é ñóäîâ³é ñïðàâ³, ÿêà ðîçãëÿäàºòüñÿ çà ïðàâèëàìè çàãàëüíîãî ïîçîâíîãî ïðîâàäæåííÿ, ïðîâîäèòüñÿ ï³äãîòîâ÷å çàñ³äàííÿ. Äàòà ³ ÷àñ ï³äãîòîâ÷îãî çàñ³äàííÿ ïðèçíà÷àþòüñÿ ñóääåþ ç óðàõóâàííÿì îáñòàâèí ñïðàâè ³ íåîáõ³äíîñò³ â÷èíåííÿ â³äïîâ³äíèõ ïðîöåñóàëüíèõ ä³é. Ï³äãîòîâ÷å çàñ³äàííÿ ìàº áóòè ðîçïî÷àòå íå ï³çí³øå í³æ ÷åðåç òðèäöÿòü äí³â ç äíÿ â³äêðèòòÿ ïðîâàäæåííÿ ó ñïðàâ³.</FONT></P>
<P class="ps1"><FONT class="fs130">          Çà òàêèõ îáñòàâèí, ñóä ââàæàº çà íåîáõ³äíå ïðèçíà÷èòè ó ñïðàâ³ ï³äãîòîâ÷å çàñ³äàííÿ òà âñòàíîâèòè ó÷àñíèêàì ñïðàâè ñòðîêè äëÿ ïîäàííÿ íèìè äîêóìåíò³â íà ï³äòâåðäæåííÿ ñâîº¿ ïðàâîâî¿ ïîçèö³¿ â äàíîìó ñïîð³ ç óðàõóâàííÿì âèìîã ÷àñòèíè 8 ñòàòò³ 165, ÷àñòèíè 4 ñòàòò³ 166 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè.</FONT></P>
<P class="ps1"><FONT class="fs129">          Ïðè öüîìó, ñóäîì âñòàíîâëåíî, ùî â³äïîâ³äà÷-1 Glaxosmithkline Trading Services Limited º þðèäè÷íîþ îñîáîþ çà çàêîíîäàâñòâîì ²ðëàíä³¿ òà íå ìàº ñâîãî ïðåäñòàâíèöòâà íà òåðèòîð³¿ Óêðà¿íè. </FONT></P>
<P class="ps2"><FONT class="fs128">²íîçåìí³ îñîáè ìàþòü òàê³ ñàì³ ïðîöåñóàëüí³ ïðàâà òà îáîâÿçêè, ùî ³ ãðîìàäÿíè Óêðà¿íè òà þðèäè÷í³ îñîáè, ñòâîðåí³ çà çàêîíîäàâñòâîì Óêðà¿íè, êð³ì âèíÿòê³â, âñòàíîâëåíèõ çàêîíîì àáî ì³æíàðîäíèì äîãîâîðîì, çãîäà íà îáîâÿçêîâ³ñòü ÿêîãî íàäàíà Âåðõîâíîþ Ðàäîþ Óêðà¿íè (ñòàòòÿ 365 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè). </FONT></P>
<P class="ps2"><FONT class="fs127">Ñòàòòåþ 367 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè ïåðåäáà÷åíî, ùî ó ðàç³ ÿêùî â ïðîöåñ³ ðîçãëÿäó ñïðàâè ãîñïîäàðñüêîìó ñóäó íåîáõ³äíî âðó÷èòè äîêóìåíòè, îòðèìàòè äîêàçè, ïðîâåñòè îêðåì³ ïðîöåñóàëüí³ ä³¿ íà òåðèòîð³¿ ³íøî¿ äåðæàâè, ãîñïîäàðñüêèé ñóä ìîæå çâåðíóòèñÿ ç â³äïîâ³äíèì ñóäîâèì äîðó÷åííÿì äî ³íîçåìíîãî ñóäó àáî ³íøîãî êîìïåòåíòíîãî îðãàíó ³íîçåìíî¿ äåðæàâè (äàë³ - ³íîçåìíèé ñóä) ó ïîðÿäêó, âñòàíîâëåíîìó öèì Êîäåêñîì àáî ì³æíàðîäíèì äîãîâîðîì, çãîäà íà îáîâÿçêîâ³ñòü ÿêîãî íàäàíà Âåðõîâíîþ Ðàäîþ Óêðà¿íè. Ñóäîâå äîðó÷åííÿ íàäñèëàºòüñÿ ó ïîðÿäêó, âñòàíîâëåíîìó öèì Êîäåêñîì àáî ì³æíàðîäíèì äîãîâîðîì, çãîäà íà îáîâÿçêîâ³ñòü ÿêîãî íàäàíà Âåðõîâíîþ Ðàäîþ Óêðà¿íè, à ÿêùî ì³æíàðîäíèé äîãîâ³ð íå óêëàäåíî - Ì³í³ñòåðñòâó þñòèö³¿ Óêðà¿íè, ÿêå íàäñèëàº äîðó÷åííÿ Ì³í³ñòåðñòâó çàêîðäîííèõ ñïðàâ Óêðà¿íè äëÿ ïåðåäà÷³ äèïëîìàòè÷íèìè êàíàëàìè.</FONT></P>
<P class="ps2"><FONT class="fs126">Ïîðÿäîê ïåðåäà÷³ ñóäîâèõ òà ïîçàñóäîâèõ äîêóìåíò³â äëÿ âðó÷åííÿ íà òåðèòîð³¿ ²ðëàíä³¿ ðåãóëþºòüñÿ Êîíâåíö³ºþ "Ïðî âðó÷åííÿ çà êîðäîíîì ñóäîâèõ òà ïîçàñóäîâèõ äîêóìåíò³â ó öèâ³ëüíèõ àáî êîìåðö³éíèõ ñïðàâàõ" â³ä 15.11.1965, äî ÿêî¿ Óêðà¿íà ïðèºäíàëàñÿ 19.10.2000, ïðèéíÿâøè â³äïîâ³äíèé íîðìàòèâíèé àêò - Çàêîí Óêðà¿íè "Ïðî ïðèºäíàííÿ Óêðà¿íè äî Êîíâåíö³¿ ïðî âðó÷åííÿ çà êîðäîíîì ñóäîâèõ òà ïîçàñóäîâèõ äîêóìåíò³â ó öèâ³ëüíèõ àáî êîìåðö³éíèõ ñïðàâàõ".</FONT></P>
<P class="ps2"><FONT class="fs125">Â³äïîâ³äíî äî ñòàòò³ 1 âêàçàíî¿ Êîíâåíö³¿, ïåðåäáà÷åíî, ùî öÿ Êîíâåíö³ÿ çàñòîñîâóºòüñÿ ó öèâ³ëüíèõ àáî êîìåðö³éíèõ ñïðàâàõ ùîäî âñ³õ âèïàäê³â, êîëè ³ñíóº ïîòðåáà â ïåðåäà÷³ ñóäîâèõ òà ïîçàñóäîâèõ äîêóìåíò³â äëÿ âðó÷åííÿ çà êîðäîíîì.</FONT></P>
<P class="ps2"><FONT class="fs124">Çã³äíî ç ïóíêòîì à ÷àñòèíè 1 ñòàòò³ 10 Êîíâåíö³¿ ÿêùî çàïèòóâàíà äåðæàâà íå çàïåðå÷óº, òî öÿ Êîíâåíö³ÿ íå îáìåæóº ìîæëèâîñò³ íàäñèëàòè ñóäîâ³ äîêóìåíòè áåçïîñåðåäíüî ïîøòîþ îñîáàì, ÿê³ ïåðåáóâàþòü çà êîðäîíîì.</FONT></P>
<P class="ps2"><FONT class="fs123">Â òîé æå ÷àñ, íà â³äì³íó â³ä Óêðà¿íè, ÿêà ï. 5 Çàêîíó Óêðà¿íè â³ä 19.10.2000 ¹ 2052-III ïðèºäíàëàñÿ äî Êîíâåíö³¿ ³ç çàñòåðåæåííÿ â ò.÷. ùîäî íå âèêîðèñòîâóâàííÿ íà ñâî¿é òåðèòîð³¿ ñïîñîá³â ïåðåäà÷³ ñóäîâèõ äîêóìåíò³â, ïåðåäáà÷åíèõ ñòàòòåþ 10 Êîíâåíö³¿, ²ðëàíä³ÿ ïðè ïðèºäíàíí³ äî Êîíâåíö³¿ çàñòåðåæåíü ùîäî íåçàñòîñóâàííÿ ñò. 10 Êîíâåíö³¿ íå ðîáèëà, à â³äòàê ï. à) ñò. 10 Êîíâåíö³¿ íå îáìåæóº ìîæëèâîñò³ íàäñèëàòè ñóäîâ³ äîêóìåíòè îñîáàì, ì³ñöåçíàõîäæåííÿì ÿêèõ º ²ðëàíä³ÿ, áåçïîñåðåäíüî ïîøòîþ.</FONT></P>
<P class="ps2"><FONT class="fs122">Òàêèì ÷èíîì, ç ìåòîþ íàëåæíîãî ïîâ³äîìëåííÿ â³äïîâ³äà÷à-1 Glaxosmithkline Trading &nbsp;Services Limited ïðî ÷àñ ³ ì³ñöå ðîçãëÿäó äàíî¿ ñïðàâè, âðàõîâóþ÷è ïðèïèñè ñò. 10 Êîíâåíö³¿ òà ïîçèö³þ Óðÿäó ²ðëàíä³¿, ñïîñ³á â³äïðàâëåííÿ ñóäîâèõ äîêóìåíò³â â³äïîâ³äà÷ó-1 çä³éñíþºòüñÿ áåçïîñåðåäíüî çà àäðåñîþ éîãî ì³ñöåçíàõîäæåííÿ. </FONT></P>
<P class="ps1"><FONT class="fs121">          Êåðóþ÷èñü ñòàòòÿìè 120, 121, 176, 367 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè, ãîñïîäàðñüêèé ñóä ì³ñòà Êèºâà,-</FONT></P>
<P class="ps4"><FONT class="fs97">ÓÕÂÀËÈÂ:</FONT></P>
<P class="ps2"><FONT class="fs120">1.          Ïðèéíÿòè ïîçîâíó çàÿâó äî ðîçãëÿäó òà â³äêðèòè ïðîâàäæåííÿ ó ñïðàâ³.</FONT></P>
<P class="ps2"><FONT class="fs119">2.          Ñïðàâó ðîçãëÿäàòè çà ïðàâèëàìè çàãàëüíîãî ïîçîâíîãî ïðîâàäæåííÿ.</FONT></P>
<P class="ps2"><FONT class="fs118">3.          Ï³äãîòîâ÷å çàñ³äàííÿ ïðèçíà÷èòè </FONT><FONT class="fs96">íà &nbsp;07.02.18 ð. î 12:45 ãîä.</FONT><FONT class="fs117"> Çàñ³äàííÿ â³äáóäåòüñÿ â ïðèì³ùåíí³ ãîñïîäàðñüêîãî ñóäó ì³ñòà Êèºâà çà àäðåñîþ: ì. Êè¿â, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;âóë. Á. Õìåëüíèöüêîãî, 44-Á, çàë ñóäîâèõ çàñ³äàíü </FONT><FONT class="fs95">¹ 2.</FONT></P>
<P class="ps2"><FONT class="fs116">4.          Âèêëèêàòè ó ï³äãîòîâ÷å çàñ³äàííÿ ïðåäñòàâíèê³â ó÷àñíèê³â ñïðàâè, ÿêèì íåîáõ³äíî ïðè ñîá³ ìàòè äîêóìåíòè, ùî ï³äòâåðäæóþòü ¿õ ïîâíîâàæåííÿ â³äïîâ³äíî äî ñòàòò³ 60 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè. </FONT></P>
<P class="ps2"><FONT class="fs115">5.          ßâêó ïðåäñòàâíèê³â ïîçèâà÷à òà â³äïîâ³äà÷à â ï³äãîòîâ÷å ñóäîâå çàñ³äàííÿ âèçíàòè îáîâÿçêîâîþ. </FONT></P>
<P class="ps2"><FONT class="fs114">6.          Çîáîâÿçàòè ïîçèâà÷à â òåðì³í äî 22.01.2018 ïîäàòè ñóäó íîòàð³àëüíî çàñâ³ä÷åíèé ïåðåêëàä óõâàëè ãîñïîäàðñüêîãî ñóäó ì³ñòà Êèºâà â³ä 09.01.2017 ïðî â³äêðèòòÿ ïðîâàäæåííÿ ó ñïðàâ³ ¹ 910/153/18 òà êîï³þ ïîçîâíî¿ çàÿâè ç äîäàòêàìè äî íå¿ íà àíãë³éñüêó ìîâó ó äâîõ ïðèì³ðíèêàõ.</FONT></P>
<P class="ps2"><FONT class="fs113">7.          Çàïðîïîíóâàòè â³äïîâ³äà÷ó ó ñòðîê äî 07.02.2018 ïîäàòè äî ñóäó â³äçèâ íà ïîçîâíó çàÿâó, îôîðìëåíèé â³äïîâ³äíî äî âèìîã ñòàòò³ 165 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè, à òàêîæ âñ³ äîêàçè, ùî ï³äòâåðäæóþòü çàïåðå÷åííÿ ïðîòè ïîçîâó; çàáåçïå÷èòè íàïðàâëåííÿ ïîçèâà÷ó êîï³þ â³äçèâó íà ïîçîâ òà äîäàíèõ äî íüîãî äîêóìåíò³â, äîêàçè íà ï³äòâåðäæåííÿ òàêîãî íàïðàâëåííÿ íàäàòè ñóäó. Ïîïåðåäèòè &nbsp;â³äïîâ³äà÷à, ùî ó ðàç³ íåíàäàííÿ â³äçèâó ó âñòàíîâëåíèé ñóäîì ñòðîê áåç ïîâàæíèõ ïðè÷èí ñóä ìàº ïðàâî âèð³øèòè ñï³ð çà íàÿâíèìè ìàòåð³àëàìè ñïðàâè â³äïîâ³äíî äî ÷àñòèíè 2 ñòàòò³ 178 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè. Ïðè öüîìó, ÿêùî äîêàçè íå ìîæóòü áóòè ïîäàí³ ðàçîì ç â³äçèâîì ç îá'ºêòèâíèõ ïðè÷èí, â³äïîâ³äà÷ ïîâèíåí ïðî öå ïèñüìîâî ïîâ³äîìèòè ñóä òà çàçíà÷èòè: äîêàç, ÿêèé íå ìîæå áóòè ïîäàíî; ïðè÷èíè, ç ÿêèõ äîêàç íå ìîæå áóòè ïîäàíî ó çàçíà÷åíèé ñòðîê; äîêàçè, ÿê³ ï³äòâåðäæóþòü, ùî îñîáà çä³éñíèëà âñ³ çàëåæí³ â³ä íå¿ ä³¿, ñïðÿìîâàí³ íà îòðèìàííÿ âêàçàíîãî äîêàçó (÷àñòèíè 3, 4 ñòàòò³ 80 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè).</FONT></P>
<P class="ps2"><FONT class="fs112">8.          Çàïðîïîíóâàòè ïîçèâà÷ó ó ñòðîê äî 07.02.2018 ðîêó ïîäàòè â³äïîâ³äü íà â³äçèâ â ïîðÿäêó ñòàòò³ 166 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè, êîï³þ ÿêîãî íàïðàâèòè â³äïîâ³äà÷ó â òîé ñàìèé ñòðîê. </FONT></P>
<P class="ps2"><FONT class="fs111">9.</FONT><FONT class="fs169">           </FONT><FONT class="fs110">Óñ³ çàÿâè, êëîïîòàííÿ, çàïåðå÷åííÿ ïîäàòè äî ñóäó â ñòðîê äî 07.02.2018 ç äîòðèìàííÿì âèìîã äî ôîðìè òà çì³ñòó çàÿâ ç ïðîöåñóàëüíèõ ïèòàíü, âñòàíîâëåíèõ ñòàòòåþ 170 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè.</FONT></P>
<P class="ps2"><FONT class="fs109">10.          Ïîïåðåäèòè ïîçèâà÷à ïðî íàñë³äêè, ïåðåäáà÷åí³ ïóíêòîì 4 ÷àñòèíè 1 ñòàòò³ 226 Ãîñïîäàðñüêîãî ïðîöåñóàëüíîãî êîäåêñó Óêðà¿íè. </FONT></P>
<P class="ps2"><FONT class="fs108">11.          Óõâàëà íàáèðàº çàêîííî¿ ñèëè 09.01.2018 ðîêó òà îñêàðæåííþ íå ï³äëÿãàº. </FONT></P>
<P class="ps2"><FONT class="fs94">Ñóääÿ                                                                                                    Ì.ª. Ë³òâ³íîâà</FONT></P>
<P><FONT class="fs85"> </FONT></P>